Sunshine Biopharma (SBFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 5,561 | 4,894 | 3,940 | 133 | 150 |
| Cost of Goods | 3,608 | 3,066 | 2,449 | 66 | 75 |
| Gross Profit | 1,953 | 1,828 | 1,491 | 67 | 76 |
| Operating Expenses | 3,575 | 3,723 | 25,304 | 1,851 | 846 |
| Operating Income | -1,014 | -1,829 | -23,364 | -1,718 | -696 |
| Interest Expense | 3 | 41 | 27 | 0 | 0 |
| Other Income | 203 | 214 | 111 | 261 | 157 |
| Pre-tax Income | -814 | -1,656 | -23,279 | -1,457 | -539 |
| Income Tax | 88 | 46 | N/A | N/A | N/A |
| Net Income Continuous | -902 | -1,702 | -23,512 | -1,457 | -539 |
| Net Income | $-902 | $-1,702 | $-23,512 | $-1,457 | $-539 |
| EPS Basic Total Ops | -71.17 | -154.60 | -2,840.00 | -160.00 | -60.00 |
| EPS Basic Continuous Ops | -71.17 | -154.77 | -2,832.21 | -154.30 | -68.00 |
| EPS Diluted Total Ops | -71.17 | -154.60 | -2,840.00 | -160.00 | -60.00 |
| EPS Diluted Continuous Ops | -71.17 | -154.77 | -2,832.21 | -154.30 | -68.00 |
| EBITDA(a) | $-979 | $-1,794 | $-5,018 | $-1,717 | $-694 |